shukra pharmaceuticals limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 16 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 35 bids — SWARN SINGH KHURANA AND SONS appeared in 3 of them.
SHUKRA PHARMACEUTICALS LIMITED
SHUKRA PHARMACEUTICALS LIMITED
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
647
Contract Value
₹168.85 Cr
L1 Bids
247
Recent Win Rate
29.2%
Performance Analytics
Shukra Pharmaceuticals Limited: Business Analysis & Government Tender Performance
Shukra Pharmaceuticals Limited exhibits a strong presence in the government tender landscape, participating in 647 government tenders. This business analysis delves into their bidding performance, success patterns, and competitive positioning within the pharmaceutical sector, focusing on key performance indicators (KPIs) and strategic recommendations for future growth.
Executive Summary
Shukra Pharmaceuticals Limited has demonstrated a robust engagement in government procurement, evidenced by their participation in 647 tenders. A key highlight is their 38.2% win rate, indicative of their strategic approach to bidding. The company has secured 247 L1 positions, underscoring their competitive pricing and effective bid strategy. Financial performance in government tenders reveals a successful conversion of bid value to won contracts, signaling their proficiency in targeting and securing valuable public sector projects. However, recent trends indicate a decline in win rate, necessitating a strategic review to maintain competitiveness.
Financial Performance of Shukra Pharmaceuticals Limited
Key Financial Metrics
- Total Contract Value: Shukra Pharmaceuticals Limited has secured contracts worth ₹1,68,85,33,283.0 from government tenders.
- Win Rate: The company boasts an overall win rate of 38.2% across all tender participations.
- L1 Bids: Securing 247 L1 positions showcases a strong competitive edge in pricing and bid strategy.